News Update: Questcor Falls as FDA Approval for MS Drug to Treat Babies’ Seizures Delayed

Published April 23, 2014

News Update: Questcor Falls as FDA Approval for MS Drug to Treat Babies’ Seizures Delayed — Questcor Pharmaceuticals Inc. (QCOE) is slumping before the opening bell as its multiple sclerosis drug Acthar has not yet been approved by the FDA for use t…

Nitto Denko Develops RNAi-Based Drug for Fibrosis Treatment in Liver and …
Nitto Denko Corporation (Nitto) has been developing a new RNAi based drug for treating fibrosis in liver and other organs since 2008 in collaboration with Prof.Yoshiro Niitsu of Sapporo Medical University. In June 2013, Nitto initiated a phase-1 …
Read more on AZoNano.com

New hepatitis C drug treatment 'shows promise'
"A new treatment for hepatitis C 'cured' 90% of patients with the infection in 12 weeks, scientists said," BBC News reports after a new drug protocol designed to target the protein that assists the spread of the virus through the body has shown …
Read more on NHS Choices

Canton man sentenced to drug treatment in robbery case
GlenOak grad Erica McNew heating up at Cleveland State … Indians activate Giambi, demote Blake Wood … Canton man sentenced to drug treatment in robbery case. The second co-defendant in a robbery and burglary case was sentenced on Monday in …
Read more on Canton Repository

More Drug Treatment News Information…